Fig. 4From: Transcriptomic analysis identifies CYP27A1 as a diagnostic marker for the prognosis and immunity in lung adenocarcinomaPrognostic value of CYP27A1 in the different subgroups. The overall survival (A) and disease-specific survival (B) in all LUAD patients. The overall survival in LUAD patients for N0 stage (C), anatomic neoplasm subdivision (D), and male (E) subgroupsBack to article page